Civic Intelligence

Catalyst Global

990 • Fiscal year 2018 • EIN 46-3226871

Jan 01, 2018 to Dec 31, 2018

Carlsbad, CA
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

76th percentile

0.39x

Higher debt load relative to assets than 76% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2018

Liabilities / Revenue

58th percentile

0.14x

Higher debt load relative to revenue than 58% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2018

Net Margin

74th percentile

16%

Higher net margin than 74% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2018

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2018

Asset Growth

47th percentile

0.2%

Faster asset growth than 47% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2017 to 2018

Revenue Growth

56th percentile

6.4%

Faster revenue growth than 56% of similar nonprofits.

2018 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2017 to 2018

Assets

Up

$1,668,857

Up $3,692 (+0.2%) from 2017

Net Assets

Up

$1,023,567

Up $751,591 (+276%) from 2017

Liabilities

Down

$645,290

Down $747,899 (-54%) from 2017

Revenue

Up

$4,593,281

Up $277,144 (+6.4%) from 2017

Expenses

Down

$3,841,690

Down $268,242 (-6.5%) from 2017

Net Income

Up

$751,591

Up $545,386 (+264%) from 2017

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$3.0M$2.0M$1.0M$0Assets 2017: $1,665,165Liabilities 2017: $1,393,189Net Assets 2017: $271,9762017Assets 2018: $1,668,857Liabilities 2018: $645,290Net Assets 2018: $1,023,5672018Assets 2019: $2,158,512Liabilities 2019: $438,332Net Assets 2019: $1,720,1802019Assets 2020: $2,262,556Liabilities 2020: $422,735Net Assets 2020: $1,839,8212020Assets 2021: $2,144,515Liabilities 2021: $533,071Net Assets 2021: $1,611,4442021Assets 2022: $1,587,051Liabilities 2022: $451,481Net Assets 2022: $1,135,5702022Assets 2023: $582,950Liabilities 2023: $85,385Net Assets 2023: $497,5652023

Highlighted filing

2018

Assets$1,668,857
Liabilities$645,290
Net Assets$1,023,567

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2017: $4,316,137Expenses 2017: $4,109,932Net Income 2017: $206,2052017Revenue 2018: $4,593,281Expenses 2018: $3,841,690Net Income 2018: $751,5912018Revenue 2019: $3,449,389Expenses 2019: $2,752,776Net Income 2019: $696,6132019Revenue 2020: $2,882,300Expenses 2020: $2,762,659Net Income 2020: $119,6412020Revenue 2021: $2,918,913Expenses 2021: $3,147,290Net Income 2021: -$228,3772021Revenue 2022: $3,162,763Expenses 2022: $3,638,637Net Income 2022: -$475,8742022Revenue 2023: $2,074,009Expenses 2023: $2,712,014Net Income 2023: -$638,0052023

Highlighted filing

2018

Revenue$4,593,281
Expenses$3,841,690
Net Income$751,591
Filing Detail Status

This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview

Mission

Catalyst Global (formerly known as WCG Cares) is an international non-profit organization committed to increasing access to innovative, high-quality, affordable sexual and reproductive health products and services to facilitate the vibrant health, well-being, and future of girls and women. Catalyst Globals credentials in product introduction have made it a preferred partner of organizations looking to move products from laboratories and manufacturing plants to the women who need them. Catalyst Global excels at forming strategic partnerships to introduce and create access to new contraceptive methods around the world. Catalyst Globals quality and regulatory departments are experienced in the global registration of drugs and devices, and in aiding manufacturers to improve their processes to meet international best practices. We create options for women when it comes to their reproductive health - no matter where they live.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings